Yoshisato Shibata Selected Research

Yoshisato Shibata Research Topics

Disease

31	Myocardial Infarction 01/2024 - 11/2008
13	Thrombosis (Thrombus) 01/2024 - 07/2006
10	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2004
9	ST Elevation Myocardial Infarction 02/2024 - 04/2016
9	Hemorrhage 07/2023 - 01/2012
8	Heart Failure 10/2022 - 01/2004
7	Atrial Fibrillation 07/2023 - 10/2016
7	Stroke (Strokes) 07/2023 - 01/2018
6	Unstable Angina 01/2021 - 02/2003
5	Non-ST Elevated Myocardial Infarction 01/2022 - 06/2017
4	Death (Near-Death Experience) 12/2023 - 05/2018
4	Stable Angina 01/2022 - 02/2003
4	Acute Coronary Syndrome 01/2022 - 01/2017
3	Atherosclerosis 01/2024 - 10/2021
3	Embolism (Embolus) 07/2023 - 01/2022
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2023 - 10/2017
3	Type 2 Diabetes Mellitus (MODY) 11/2018 - 01/2017
2	Cardiogenic Shock 01/2022 - 08/2020
2	Hypertension (High Blood Pressure) 01/2022 - 01/2004
2	Myocarditis (Carditis) 01/2022 - 01/2021
2	No-Reflow Phenomenon 07/2021 - 12/2019
2	Atherosclerotic Plaque (Atheroma) 02/2021 - 01/2012
2	Frailty 01/2021 - 08/2020
2	Mitral Valve Insufficiency (Mitral Regurgitation) 10/2019 - 01/2016
2	Infarction (Infarctions) 09/2018 - 04/2016
2	Ischemia 10/2016 - 11/2010
1	Hyperuricemia 01/2024
1	Disease Progression 01/2024
1	Coronary Restenosis 01/2024
1	Cerebral Infarction 07/2023
1	Aortic Dissection 07/2023
1	AIDS-Related Complex (ARC) 01/2023
1	Peripheral Arterial Disease 10/2021
1	Anemia 10/2021
1	Coronary Aneurysm (Aneurysm, Coronary) 08/2021
1	Rupture 02/2021
1	Pathologic Constriction (Stenosis) 01/2021
1	Chronic Renal Insufficiency 01/2021

Drug/Important Bio-Agent (IBA)

11	omega-Chloroacetophenone (Mace)IBA 12/2023 - 11/2010
5	LipidsIBA 02/2024 - 01/2012
5	Creatine Kinase (Creatine Phosphokinase)IBA 01/2024 - 06/2017
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2024 - 10/2016
3	Warfarin (Coumadin)FDA LinkGeneric 07/2023 - 01/2022
3	Serum AlbuminIBA 01/2022 - 08/2020
3	TroponinIBA 01/2021 - 06/2017
2	PTX3 proteinIBA 01/2024 - 01/2012
2	AnticoagulantsIBA 07/2023 - 10/2022
2	Everolimus FDA Link 01/2023 - 11/2019
2	Clopidogrel (Plavix)FDA Link 01/2022 - 10/2017
2	Indicators and Reagents (Reagents)IBA 01/2022 - 09/2020
2	Proteins (Proteins, Gene)FDA Link 10/2021 - 02/2021
2	C-Reactive ProteinIBA 01/2012 - 02/2003
1	Paclitaxel (Taxol)FDA LinkGeneric 02/2024
1	Angiotensin Receptor AntagonistsIBA 01/2024
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2024
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2024
1	Xanthine OxidaseIBA 01/2024
1	Febuxostat FDA Link 01/2024
1	Biomarkers (Surrogate Marker)IBA 01/2024
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 07/2023
1	Bio-glueIBA 07/2023
1	CalciumIBA 01/2023
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2022
1	salicylhydroxamic acid (SHAM)IBA 01/2022
1	Eplerenone (Inspra)FDA LinkGeneric 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	AlbuminsIBA 01/2022
1	Mineralocorticoid Receptor AntagonistsIBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	Hemoglobins (Hemoglobin)IBA 01/2022
1	MetalsIBA 01/2022
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	Streptokinase FDA Link 01/2022
1	Complement C1q (C1q Complement)IBA 01/2022
1	CholesterolIBA 10/2021
1	BilirubinIBA 02/2021
1	von Willebrand FactorIBA 02/2021
1	IronIBA 02/2021
1	FibrinIBA 02/2021
1	Hematoxylin (Haematoxylon)IBA 01/2021
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021
1	Coloring Agents (Dyes)IBA 01/2021
1	Brain Natriuretic Peptide (Natrecor)FDA Link 09/2020
1	Phosphotransferases (Kinase)IBA 08/2020

Therapy/Procedure

20	Percutaneous Coronary Intervention 01/2024 - 11/2008
13	Therapeutics 02/2024 - 04/2016
12	Stents 12/2023 - 01/2012
7	Drug-Eluting Stents 01/2023 - 09/2010
4	Secondary Prevention 10/2021 - 09/2018
3	Catheter Ablation 12/2022 - 10/2016
2	Cardiac Rehabilitation 10/2022 - 08/2020
2	Renal Dialysis (Hemodialysis) 01/2017 - 01/2004
1	Lasers (Laser) 04/2023
1	Electric Countershock (Cardioversion) 12/2022
1	Denervation 01/2022
1	Catheters 01/2022
1	Critical Care (Surgical Intensive Care) 01/2021
1	Activities of Daily Living (ADL) 01/2021